News
In another sign of growing scrutiny over Covid-19 vaccines, the Food and Drug Administration has asked the two makers of mRNA ...
15h
Zacks Investment Research on MSNMRNA Stock Down on Withdrawal of FDA Filing for COVID-Flu Combo ShotShares of Moderna MRNA declined nearly 8% yesterday after it announced that it had voluntarily withdrawn a regulatory filing ...
The mRNA vaccines were developed using novel technology that was approved for the first time for public use during the COVID-19 pandemic.
The US Food and Drug Administration will now require Covid-19 vaccines from Pfizer/BioNTech and Moderna to use expanded ...
This week, mRNA vaccines are set to face intense scrutiny from critics in Congress. Here's an explainer of how we know they are safe and effective.
3d
Live Science on MSN2-in-1 COVID-flu vaccine looks promising in trial — but experts say approval may be delayedLate-stage trial data suggest that a new COVID-flu vaccine offers good protection against both infections, but experts expect ...
The FDA has told vaccine manufacturers to expand the warning labels on their COVID-19 shots with more information about the ...
According to the CDC, cases of myocarditis and pericarditis are rare with the vaccines and, in most cases, resolve within a ...
Moderna has withdrawn the Biologics License Application (BLA) for mRNA-1083, a combination vaccine against seasonal influenza and SARS-CoV-2, after ...
Government signs deal to see huge investment in mRNA vaccine manufacturing which could help tackle the next pandemic and ...
The FDA is requiring COVID vaccine makers Pfizer and Moderna to update their warnings about the possible risk of myocarditis and pericarditis.
According to doctors, immunity from previous vaccines wears off over time, activating exposure to Omicron immune responses. However, mRNA vaccines give adequate protection and adaptability, so it is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results